Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Vera Golder, Rangi Kandane‐Rathnayake, Molla Huq, +19

The Lancet Rheumatology

Prospective Validation StudyAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus +5

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Vera Golder, Rangi Kandane‐Rathnayake, Alberta Hoi, +20

Arthritis Research & Therapy

Ankylosing spondylitis: an update.

Vera Golder, Lionel Schachna

PubMed

Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus

Shereen Oon, Molla Huq, Vera Golder, +3

Annals of the Rheumatic Diseases

Discordance of patient and physician health status concerns in systemic lupus erythematosus

Vera Golder, James Jian Yun Ooi, Anna Antony, +5

Lupus

Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

Diane Apostolopoulos, Rangi Kandane‐Rathnayake, Worawit Louthrenoo, +18

The Lancet Rheumatology

Rheumatoid DisorderRheumatologyAutoimmune DiseaseDisease ProgressionSystemic Lupus Erythematosus Treatment +9

Association of Asian ethnicity with disease activity in SLE: an observational study from the Monash Lupus Clinic

Vera Golder, Kim A. Connelly, Margaret Staples, +2

Lupus

Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus

Eric F. Morand, Gabriel Abreu, Richard Furie, +2

Annals of the Rheumatic Diseases

Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

Vera Golder, Rangi Kandane‐Rathnayake, Molla Huq, +18

The Lancet Rheumatology

Remission DefinitionsAutoimmune DiseaseSystemic Lupus ErythematosusDisease ProgressionLupus +7

Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

Rangi Kandane‐Rathnayake, Vera Golder, Worawit Louthrenoo, +37

The Lancet Rheumatology

Longitudinal Cohort StudyAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus +6